InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Hume Daniel, 董事. Director active across 1 company, notably TG Therapeutics, INC.. Cumulatively, 6 reports have been logged. Activity tracked since 18 June 2021. The latest transaction was filed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hume Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
14,718 股0Common StockSEC:0001437749-25-020541:0
62,459 股0Common StockSEC:0001437749-25-008284:0
22,250 股0Common StockSEC:0001437749-24-020850:0
20,000 股0Common StockSEC:0001104659-23-105400:0
43,732 股0Common StockSEC:0001104659-22-082022:0
20,000 股0COMMON STOCKSEC:0001104659-21-084259:0
6 条申报中的 6 条
About Hume Daniel
Daniel Hume is a Director at TG THERAPEUTICS, INC. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector and understanding of market challenges allow him to provide valuable insights during board discussions.
